Liberalis D. Boila

Salt Lake
Kolkata, WB, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer.

ZNF274 constrains lineage plasticity and drives intrinsic resistance to CDK7 inhibitors in pancreatic cancer.

Journal: Nature communications

Published: May 14, 2025

SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.

SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma.

Journal: Science translational medicine

Published: May 15, 2024

Unifying targeted therapy for leukemia in the era of PARP inhibition.

Unifying targeted therapy for leukemia in the era of PARP inhibition.

Journal: Experimental hematology

Published: March 13, 2023

KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.

KDM6 demethylases integrate DNA repair gene regulation and loss of KDM6A sensitizes human acute myeloid leukemia to PARP and BCL2 inhibition.

Journal: Leukemia

Published: September 14, 2022

Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.

Evolving insights on histone methylome regulation in human acute myeloid leukemia pathogenesis and targeted therapy.

Journal: Experimental hematology

Published: June 26, 2020

A Potent Conformation-Constrained Synthetic Peptide Mimic of a Homeodomain Selectively Regulates Target Genes in Cells.

A Potent Conformation-Constrained Synthetic Peptide Mimic of a Homeodomain Selectively Regulates Target Genes in Cells.

Journal: ACS chemical biology

Published: July 03, 2018

SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.

SMARCB1 Deficiency Integrates Epigenetic Signals to Oncogenic Gene Expression Program Maintenance in Human Acute Myeloid Leukemia.

Journal: Molecular cancer research : MCR

Published: September 08, 2017

KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.

KDM6 and KDM4 histone lysine demethylases emerge as molecular therapeutic targets in human acute myeloid leukemia.

Journal: Experimental hematology

Published: August 08, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026